Micro/Nanoparticle Delivery Systems for Ocular Diseases.
Assay Drug Dev Technol
; 17(4): 152-166, 2019.
Article
en En
| MEDLINE
| ID: mdl-31090439
Micro- (MPs) and nanoparticles (NPs) have been recently studied for their application in ophthalmic drug delivery. These drug delivery systems are able to circumvent the ocular barriers that currently limit the efficacy of conventional treatments, as well as provide a more sustained release of drug, reducing the frequency of administration and increasing patient compliance. This review summarizes the recent trends in ophthalmic research from conventional treatment to the utilization of MPs and NPs as drug carriers.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Síndromes de Ojo Seco
/
Glaucoma
/
Sistemas de Liberación de Medicamentos
/
Nanopartículas
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Assay Drug Dev Technol
Asunto de la revista:
FARMACOLOGIA
Año:
2019
Tipo del documento:
Article
Pais de publicación:
Estados Unidos